Buprenorphine references

1. Berrocoso, E., et al., Opiates as antidepressants. Curr Pharm Des, 2009. 15(14): p. 1612-22.

2. Stanciu, C.N., O.M. Glass, and T.M. Penders, Use of Buprenorphine in treatment of refractory depression-A review of current literature. Asian J Psychiatr, 2017. 26: p. 94-98.

3. Weber, M.M. and H.M. Emrich, Current and historical concepts of opiate treatment in psychiatric disorders. Int Clin Psychopharmacol, 1988. 3(3): p. 255-66.

4. Ahmadi, J., M.S. Jahromi, and Z. Ehsaei, The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial. Trials, 2018. 19(1): p. 462.

5. Yovell, Y., et al., Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. Am J Psychiatry, 2016. 173(5): p. 491-8.

6. Striebel, J.M. and R.K. Kalapatapu, The anti-suicidal potential of buprenorphine: a case report. Int J Psychiatry Med, 2014. 47(2): p. 169-74.

7. Emrich, H.M., P. Vogt, and A. Herz, Possible antidepressive effects of opioids: action of buprenorphine. Ann N Y Acad Sci, 1982. 398: p. 108-12.

8. Bodkin, J.A., et al., Buprenorphine treatment of refractory depression. J Clin Psychopharmacol, 1995. 15(1): p. 49-57.

9. Nyhuis, P.W., M. Gastpar, and N. Scherbaum, Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy. J Clin Psychopharmacol, 2008. 28(5): p. 593-5.

10. Ahmadpanah, M., et al., Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial. J Psychiatr Res, 2017. 94: p. 23-28.

11. Kellner, C.H., et al., A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study. Am J Psychiatry, 2016. 173(11): p. 1110-1118.

12. Fava, M., et al., Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies. Mol Psychiatry, 2020. 25(7): p. 1580-1591.